India’s alarming ‘fixed dose combination’ problem
Context: A new study reveals that a huge volume of unapproved and even banned fixed dose combinations (FDC) of antibiotics are being sold in India. In 2020, 60.5% FDCs of antibiotics were unapproved and another 9.9% were being sold despite being banned in India. […]